BSPED24

Tuesday 8 October

08:00-19:00Registration
Reception Foyer (Level 3)
08:50-09:00Welcome and Introduction by CME Officer
Ballroom 2
08:50Welcome and Introduction
09:00-10:00CME Symposium (1)
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Tarini Chetty (Edinburgh, UK)
Ballroom 2
9:00Role of genomics in Paediatric Endocrinology
9:30Mechanisms of Disease in Primary Adrenal Insufficiency
10:00-10:30CME Oral Communications 1
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Tarini Chetty (Edinburgh, UK)
Ballroom 2
10:00OC1.1Phenotypic diversity in siblings with a rare cause of Hypophosphataemic rickets
10:15OC1.2A case of Kearns-Sayer Syndrome Presenting with Hypoglycaemia and Adrenal Insufficiency
10:30-11:00Tea & Coffee Break
Ballroom 1
11:00-12:00CME Symposium 2
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Harriet Gunn (London, UK)
Ballroom 2
11:00Interpretation of abnormal thyroid function tests in children and adoloscents
11:30Decoding Bone Profile
12:00-12:30CME Oral Communications 2
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Harriet Gunn (London, UK)
Ballroom 2
12:00OC2.1Facial Asymmetry Revealing Hypothyroidism and Pituitary Hyperplasia in a Young Child
12:15OC2.216 Years of Learning: The First Patient Treated with Asfotase Alfa for Perinatal Hypophosphatasia
12:30-13:00 CSAC Trainee Representative
Spey
12:40-13:30Lunch and Exhibition
Ballroom 1
13:30-14:30CME Symposium 3
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Elizabeth VanBoxel (Southampton, UK)
Ballroom 2
13:30Insulin resistance-mechanisms, conditions and management
14:00Diabetes in children and young adults – Getting it right first time
14:30-15:00CME Oral Communications 3
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr Elizabeth VanBoxel (Southampton, UK)
Ballroom 2
14:30OC3.1Phenotypic features of two brothers with a rare X-linked insulin receptor substrate 4 (IRS4) mutation and the suspected role of IRS4 in the HPT axis
14:45OC3.2Diabetes and deafness: not just Wolfrom
15:00-15:30Tea & Coffee Break
Ballroom 1
15:30-16:00CME Symposium 4
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr James Law (Nottingham, UK)
Ballroom 2
15:30Testicular disorders and future fertility
16:00-16:30CME Oral Communications 4
Chair(s): Dr Dinesh Giri (Bristol, UK) & Dr James Law (Nottingham, UK)
Ballroom 2
16:00OC4.1Reassessing Pancreatectomy in Diffuse Congenital Hyperinsulinism: A Tale of Two Brothers with Homozygous KCNJ11 Variants
16:15OC4.2An Unusual Presentation of Paediatric Sarcoidosis
16:30-16:45CME Officer Update & Conclusion
Ballroom 2
16:30CME Officer Update & Conclusion
17:00-17:45Satellite Symposium
For more information please see the satellite programme
19:00-21:00Civic Reception hosted by the The Rt Hon The Lord Provost and Glasgow City Council

Wednesday 9 October

08:00-18:30Registration
Reception Foyer (Level 3)
09:00-09:10Welcome and Introduction
Chair(s): Renuka Dias (Birmingham, UK) & Guftar Shaikh (Glasgow, UK)
Ballroom 2
09:20-10:50Endocrine Oral Communications 1
Chair(s): Charlotte Elder (Sheffield, UK) & Tabitha Randell (Nottingham, UK)
Ballroom 2
09:20OC5.1BRINP2 Gene Variants are Implicated in Severe Delayed Puberty Associated with Neurodevelopmental Phenotypes
09:30OC5.2Minipuberty: A Golden Phase for Optimal Treatment. Recombinant Gonadotropin Therapy During Minipuberty in Males with Hypogonadotropic Hypogonadism: A Case Series
09:40OC5.3Crinecerfont in Children and Adolescents with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Results from the Phase 3 CAHtalyst Pediatric Study
09:50OC5.4Premature Adrenarche, Body Composition and Metabolic Dysfunction – A Pilot Study
10:00OC5.5Glucocorticoid replacement therapy in congenital adrenal hyperplasia and its associations with growth outcomes - real world data analysis from an international cohort of 1500 patients.
10:10OC5.6Diagnostic testing using gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in England
10:20OC5.7A novel human disorder: QSOX2 deficiency-induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease.
10:30OC5.8Oral risedronate therapy in Duchenne muscular dystrophy: The John Walton Muscular Dystrophy Centre Experience
10:40OC5.9Genomic diagnoses in DSDs – 10-year experience from a regional DSD service
09:20-10:50CEW (Obesity) Symposium
Chair(s): Senthil Senniappan (Liverpool, UK) and Neil Wright (Sheffield, UK)
Ballroom 3
09:20Bariatric surgery
09:50How do we work with young people who experience binge eating.
10:20What's new in obesity management?
09:20-10:00PENS Annual Meeting
Spey
10:00-10:25PENS BSPED Prize
Spey
10:25-10:50PENS Nurse Presentation
Spey
10:25PENS Nurse Presentation
10:50-11:20Tea & Coffee Break
Ballroom 1
11:20-12:20Endocrine Symposium 1
Chair(s): Dinesh Giri (Bristol, UK) & Faisal Ahmed (Glasgow, UK)
Ballroom 2
11:20Genetics of endocrine tumours
11:50Management of phaeochromocytoma and lessons for paediatricians
11:20-12:20Diabetes Symposium 1
Chair(s): Renuka Dias (Birmingham, UK) & Melanie Kershaw (Birmingham, UK)
Ballroom 3
11:20Screening in early T1D: Insights from ELSA
11:50 Immunotherapy updates in T1D
12:20-12:50Endocrine Oral Communications 2
Chair(s): Senthil Senniappan (Liverpool, UK) & Angela Lucas-Herald (Glasgow, UK)
Ballroom 2
12:20OC6.1DXA lean mass index as a predictor of loss of ambulation in Duchenne Muscular Dystrophy and potential biomarker to initiate osteoporosis therapy prior to fractures
12:26OC6.2BSPED Audit of Clinical Standards for Differences of Sexual Development (DSD)
12:32OC6.3Systematic review of cardiometabolic outcomes in young people with gender dysphoria and the impact of puberty blockers
12:38OC6.4Low-level chromosomal mosaicism does not explain the spontaneous menarche seen in some women with 45,X Turner Syndrome
12:44OC6.5Rare causes of Silver-Russell Syndrome frequently present with atypical features highlighting important implications for genetic testing and clinical management
12:20-12:50Diabetes Oral Communications 1
Chair(s): Chairs: Evelien Gevers (London, UK) & Rajeeb Rashid (Glasgow, UK)
Ballroom 3
12:20OC7.1Does severity of DKA presentation associate with autoantibody status, deprivation or ethnicity - a two-centre retrospective cohort
12:26OC7.2A regional audit of Diabetic Ketoacidosis (DKA) presentations at diagnosis of type 1 diabetes (T1DM) and DKA management.
12:32OC7.3Glycaemic control of children and young people with Type 1 Diabetes fasting during Ramadan at a single London Paediatric Diabetes unit
12:38OC7.4Short term outcomes for children with new onset diabetes and confirmed SARS-CoV-2 Infections – a case series
12:44OC7.5Comparison of glycaemic control across different ethnic and socioeconomic groups in a cohort of children using hybrid closed loop systems
12:50-14:05Lunch
Ballroom 1
13:05-13:50Poster Tours
Ballroom Foyer
13:00-13:45Satellite Symposium (2)
For more information please see the satellite programme
13:00-13:45Satellite Symposium (3)
For more information please see the satellite programme
14:05-14:35James M Tanner Award
Chair(s): Tabitha Randell (Nottingham, UK) & Renuka Dias (Birmingham, UK)
Ballroom 2
14:45-15:45How Do I? (Endocrine)
Chair(s): Paul Dimitri (Sheffield, UK) and Avril Mason (Glasgow, UK)
Ballroom 2
14:45Assessment of low trauma fractures
15:15Approach to hypoglycaemia
14:45-15:45How Do I? (Diabetes)
Chair(s): Fiona Regan (London, UK) & Karen Whyte (Glasgow, UK)
Ballroom 3
14:45Support exercise and sports performance in T1D
15:15Engage the disengaged teenager?
15:45-16:15Tea & Coffee Break
Ballroom 1
16:15-16:45Endocrine Oral Communications 3
Chair(s): Jarod Wong (Glasgow, UK) & Justin Davies (Southampton, UK)
Ballroom 2
16:15OC8.1A RETROSPECTIVE ANALYSIS OF ANTI-TPO RESULTS IN INFANTS WITH AN ABNORMAL CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING
16:21OC8.2Thyroid dysfunction in patients diagnosed with neuroblastoma who received MIBG scans.
16:27OC8.3Psychological and social characteristics of children and young people living with obesity in Portsmouth and Southampton
16:33OC8.4Impact of specialist psychology provision and outcomes for a DSD service
16:39OC8.5The effect of CFTR modulators on growth, body composition and bone health in children and adolescents with cystic fibrosis
16:15-17:15Clinical Update
Chair(s): Zainab Mohammed (Birmingham, UK) & Helen Storr (London, UK)
Ballroom 3
Fertility preservation and when to refer? (female fertility)
Fertility preservation and when to refer? (male fertility)
16:45-17:15Personal Practice Session
Chair(s): Catherine Peters (London, UK) & Amanda Peacock (Newcastle, UK)
Ballroom 2
Management of abnormal TFTs - when to hold your nerve?
17:30-18:30BSPED's 2024 AGM
Ballroom 2
19:30-23:59Conference Dinner

Thursday 10 October

08:00-16:45Registration
Reception Foyer (Level 3)
08:00-08:45Satellite Symposium (4)
For more information please see the satellite programme
09:00-10:30Diabetes Symposium 2
Chair(s): Verghese Matthew (Hull, UK) & Vaiva Kuehne (Glasgow, UK)
Ballroom 2
09:00Type 2 diabetes and new pharmacology SGLT2?
09:30Past, present and future of Closed loops
10:00Bringing Technology into Diabetes Care- from Evidence to Policy
09:00-10:30Endocrine Symposium 2 (Nurses / Endocrine Professionals Session)
Ballroom 3
09:00Prader Willi Syndrome - Role of MDT Clinic
A Guide to Growth Hormone Deficiency for New Endocrine Nurses
10:30-10:40Tea & Coffee Break
Ballroom 1
10:40-12:10Diabetes Oral Communications 2
Chair(s): Fiona Campbell (Leeds, UK) & Vaiva Kuehne (Glasgow, UK)
Ballroom 2
10:40OC9.1Award-Winning Virtual Schools Training Package Creates Capacity to Enable 78% of Children to Access Hybrid Closed Loop Therapy
10:50OC9.2Improving access to diabetes technology for CYP with Diabetes across NENC: a response to Poverty Proofing, the National Paediatric Diabetes Audit and the NHSE CORE20PLUS5.
11:00OC9.3Tackling health inequalities, engagement opportunities and metabolic management in young adults living with diabetes – Transition Safe and Sound (TraSS), an NHS England pilot.
11:10OC9.4Working Above and Below the Lines: Paediatric diabetes health care professionals’ experiences of safeguarding and child protection.
11:20OC9.5Socioeconomic status influencing the cessation of insulin pump therapy in children with Type 1 Diabetes: a cohort study
11:30OC9.6Does admission for stabilisation affect HbA1c? A Single Trust Study
11:40OC9.7Improving equity of care within a paediatric diabetes service
11:50OC9.8Understanding the lived experiences of the development and maintenance of Disordered Eating Behaviours (DEB) in Type 1 Diabetes (T1D) in paediatric diabetes care
12:00OC9.9Young People and Parent or Carers Views on Type 2 Diabetes Mellitus Care in England and Wales – insights from the PREM survey report
10:40-11:40Oral Communications 4 (Endocrine Professionals)
Chair(s): Indi Bannerjee (Manchester, UK) & James Law (Nottingham, UK)
Ballroom 3
10:40OC10.1Health-related quality of life in severe obesity: Baseline PedsQL scores from two tier 3 paediatric weight management services
10:49OC10.2The effect of lifestyle and pharmacological interventions on body composition in childhood obesity
10:58OC10.3Increased Prevalence of Hypertension in Paediatric Turner Syndrome
11:07OC10.4Education Of Sick Day Management Of Paediatric Adrenal Insufficiency: A National Survey Of Paediatric Endocrine Nurse Specialists
11:16OC10.5Single-centre review of use of Gonadotrophin-Releasing Hormone Agonists – are we outliers?
11:25OC10.6Audit of Pituitary Dysfunction Post Moderate to Severe Traumatic Brain Injury and Proposed Surveillance Guidance
11:40-12:10Oral Communications 5 (Presentation from Previous Award Winner)
Ballroom 3
11:40Establishing the incidence, prevalence and clinical features of ROHHAD syndrome in the UK
11:50CoMBAT Study: Clinical effects of Metformin on Bones in Adults with Type 1 diabetes mellitus (T1DM)
12:00Presentation Title TBC
12:10-12:25Tea & Coffee Break
Ballroom 1
12:25-13:35Plenary
Chair(s): Suet Ching Chen (Glasgow, UK) & Phil Murray (Manchester, UK)
Ballroom 2
12:25Obesity and metabolic syndrome - what can paediatricians learn from our adult colleagues?
12:55Rare Disease Registries – Joining The Dots For Collaborative Research
13:15Lessons from Rare Diseases – Repurposing Drugs and beyond
13:35-14:35Lunch
Ballroom 1
13:45-14:30Poster Tours
13:50-14:35Satellite Symposium (5)
For more information please see the satellite programme
14:40-16:10Diabetes Symposium 3
Chair(s): Tarini Chetty (Edinburgh, UK) & Noina Abid (Belfast, UK)
Ballroom 2
14:40Lessons to be learnt from the Scottish Diabetes Group
15:10Management of Rare Diabetes
15:40Diabetes in pregnancy and outcomes
14:40-16:10Endocrine Symposium 3
Chair(s): Rod Mitchell (Edinburgh, UK) and Raja Padidela (Manchester, UK)
Ballroom 3
14:40AI-Powered Breakthroughs in Paediatric Endocrinology
15:10Benchmarking in Paediatric Endocrinology
15:40Hypogonadism and effects on CVS disease
16:15-16:30BSPED 2024 Awards
Ballroom 2
16:30-16:45Close of Meeting
Ballroom 2